World's largest transfusion study in cardiac surgery changes transfusion practices

August 27, 2018, St. Michael's Hospital
Research led by Dr. David Mazer, associate scientist in the Keenan Research Centre for Biomedical Science of St. Michael's Hospital in Toronto, has found that lower thresholds for blood transfusions for cardiac surgery patients compared to traditional thresholds provide positive patient outcomes and safety at six months after surgery. Credit: St. Michael's Hospital

Lower thresholds for blood transfusions for cardiac surgery patients compared to traditional thresholds provide positive patient outcomes and safety at six months after surgery, according to the world's largest research study on this topic.

The research found that in addition to providing good six months after hospital discharge, the lower threshold—known as 'restrictive ' - reduces the amount of transfused and money spent on blood per procedure. The higher, traditional threshold is called 'liberal transfusion therapy.'

Physicians who practice the liberal transfusion approach give blood transfusions early in the surgery to prevent ' hemoglobin level from falling. Hemoglobin is the protein that allows red blood cells to deliver oxygen to body tissues. Physicians who practice a restrictive approach wait longer to see if the remains stable or if the patient has further bleeding.

These findings were presented on Sunday at the European Society of Cardiology Annual Congress in Munich, Germany by Dr. David Mazer, principal investigator on the study, anesthesiologist at St. Michael's Hospital, associate scientist in its Keenan Research Centre for Biomedical Science, and Professor of Anesthesia and Physiology at the University of Toronto, with simultaneous publication in the New England Journal of Medicine.

"Our research question was, at what point does the risk of anemia, or the risk of a lower hemoglobin, outweigh the risk of transfusion?" Dr. Mazer said. "We wanted to know whether it is safe to let your hemoglobin go to a lower level before you transfuse. The answer is yes. It'll save blood, make blood more available, reduce costs of transfusion and result in similar or better outcomes."

This work builds on Dr. Mazer's research published less than a year ago in the New England Journal of Medicine, which analyzed immediate postoperative patient outcomes. The randomized trial involved more than 5,200 patients at 74 sites in 19 countries and every continent in the world except Antarctica. At the six-month mark, data was available for 96 per cent of the patients.

Dr. Mazer, who co-led this study with Dr. Nadine Shehata, a hematologist at the Sinai Health System, and the research team found no clinical or statistical difference in four patient outcomes (death, heart attack, stroke and new kidney failure), whether the patients had contemporary restrictive therapy or traditional liberal practices. In fact, use of the restrictive transfusion protocol during and after heart surgery may actually reduce the incidence of complications in older patients, including heart attack, stroke, kidney failure and death.

"This research has already started to change transfusion practice around the world," said Dr. Mazer. "With this data at six months, we've proven the longer term safety of restrictive therapy. This approach has already been adopted into guidelines and will likely become the standard of care worldwide."

The large size of this study provides Dr. Mazer and his team additional opportunity to answer several other important questions related to and cardiac surgery.

Explore further: Definitive global transfusion study supports patient safety, positive patient outcomes

More information: C. David Mazer et al, Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery, New England Journal of Medicine (2018). DOI: 10.1056/NEJMoa1808561

Related Stories

Definitive global transfusion study supports patient safety, positive patient outcomes

November 13, 2017
Lower thresholds for blood transfusions during cardiac surgery have proven to be safe and provide good patient outcomes compared to traditional thresholds, according to the largest research study ever performed in this area. ...

Fewer heart surgery patients may have to be exposed to blood transfusions, researchers say

November 13, 2017
Not as many heart surgery patients may need to be exposed to the potential dangers of blood transfusions, according to a new study that researchers say may change current practice.

Blood management program safely reduces transfusions in orthopedic patients

August 20, 2018
A patient blood management program designed to limit the amount of transfused blood orthopedic patients undergoing common surgeries such as hip and knee replacement receive was associated with fewer transfusions, reduced ...

Blueprint to reduce wasteful blood transfusions

November 20, 2017
By analyzing data from randomized clinical trials comparing blood transfusion approaches, Johns Hopkins experts, along with colleagues at Cleveland Clinic and NYU Langone Medical Center, endorse recommendations for blood ...

AABB releases new guidelines for red blood cell transfusion

March 26, 2012
AABB (formerly known as the American Association of Blood Banks) recommends a restrictive red blood cell transfusion strategy for stable adults and children, according to new guidelines being published in Annals of Internal ...

Study finds less blood can be used in heart operations

November 13, 2017
Heart surgery requires more blood transfusions than almost any other surgical procedure.

Recommended for you

New understanding of mysterious 'hereditary swelling'

December 12, 2018
For the first time ever, biomedical researchers from Aarhus University, Denmark, report cellular defects that lead to a rare disease, hereditary angioedema (HAE), in which patients experience recurrent episodes of swelling ...

Research team traces pathway to cardioprotection in post-ischemic heart failure

December 11, 2018
During an ischemic attack, the heart is temporarily robbed of its blood supply. The aftermath is devastating: reduced heart contractility, heart cell death, and heart failure. Contributing to these detrimental changes is ...

Macrophage cells key to helping heart repair—and potentially regenerate, new study finds

December 11, 2018
Scientists at the Peter Munk Cardiac Centre have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.

Study reveals new link between atrial fibrillation and mutations in heart disease gene

December 11, 2018
Atrial fibrillation (Afib), a heart condition that causes a rapid, irregular heartbeat that increases a person's risk of stroke and heart failure, is fairly common among older adults. However, its early onset form is relatively ...

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Study: Age, race differences determine risk of stroke in women and men

December 11, 2018
A new study found that, between the ages of 45 and 74 years, white women were less likely to have a stroke than white men, but at age 75 and older, there was no difference in stroke risk between white women and men. In contrast, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.